DIDREX Drug Patent Profile
✉ Email this page to a colleague
When do Didrex patents expire, and when can generic versions of Didrex launch?
Didrex is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DIDREX is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Didrex
A generic version of DIDREX was approved as benzphetamine hydrochloride by KVK TECH on July 20th, 2010.
Summary for DIDREX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
Patent Applications: | 1,427 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DIDREX at DailyMed |
US Patents and Regulatory Information for DIDREX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | DIDREX | benzphetamine hydrochloride | TABLET;ORAL | 012427-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | DIDREX | benzphetamine hydrochloride | TABLET;ORAL | 012427-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |